FDA Inspection
Almirall, S.A.Almirall, S.A. – FDA Inspection, May 12, 2017
Record Details
This FDA Inspection record concerns Almirall, S.A., with an inspection on May 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · be29cce1-89ca-43ec-8583-0bac0f307fd8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015908
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.160(b)(2)In-process sample representation/identification
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Almirall, S.A.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Almirall, S.A.
- FDA Inspection 765155 - 2012-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.